Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

12112studies shown

Showing 3,433-3,444 of 12,112

RecruitingNCT05850689

Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Bulgaria, France, India, Lithuania, Serbia, Spain, and the United States.

Multiple locations, including Huntsville

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, France, Bulgaria, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Depression

View study

RecruitingNCT06462586

Lumateperone in the Acute Treatment of people with Bipolar Mania

This study is recruiting. It focuses on bipolarity and currently lists participation information in Bulgaria, Croatia, India, Serbia, and the United States.

Multiple locations, including Rogers

BipolarityDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity

View study

RecruitingNCT06462612

Lumateperone in the Treatment of people with Bipolar Mania

This study is recruiting. It focuses on bipolarity and currently lists participation information in Bulgaria, Romania, Serbia, and the United States.

Multiple locations, including Bentonville

BipolarityDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Romania, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity

View study

RecruitingISRCTN06123818

lymphocyte neurotransmitter markers in depression and anxiety

This study is recruiting. It focuses on depression and currently lists participation information in Venezuela.

In Venezuela

Depression, AnxietyOtherOver 18 Years

Countries: Venezuela
Sponsor: Venezuelan Institute of Scientific Investigations (Instituto Venezolano de Investigaciones Científicas) (Venezuela)
Condition: Depression, Anxiety

View study

RecruitingNCT00018057

Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

Multiple locations, including Bethesda

Depression, AnxietyOtherFrom 8 Years to 65 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression, Anxiety

View study

RecruitingNCT04945278

Self-Recognition and Self/Other Distinction Disorders in people with Psychological Vulnerability

This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.

In Bohars

SchizophreniaOtherFrom 15 Years to 25 Years

Countries: France
Sponsor: University Hospital, Brest
Condition: Schizophrenia

View study

RecruitingNCT06732284

Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task

This study is recruiting. It focuses on depression and currently lists participation information in France.

In Nîmes

DepressionBehavioralFrom 18 Years to 54 Years

Countries: France
Sponsor: Centre Hospitalier Universitaire de Nīmes
Condition: Depression

View study

RecruitingNCT04911036

The Effect of the Time of Diagnosis (Antenatal vs. Postnatal) on the Post-traumatic Reactions of Parents of Children Undergoing Oesophageal Atresia Surgery "

This study is recruiting in France. It focuses on PTSD.

In Lille

PTSDOtherOver 18 Years

Countries: France
Sponsor: University Hospital, Lille
Condition: PTSD

View study

RecruitingNCT06806267

Effectiveness of VRET Combined With tDCS in PTSD

This study is recruiting in Germany. It is testing VRET Combined With tDCS for PTSD.

In Berlin

PTSDBehavioralFrom 18 Years to 75 Years

Countries: Germany
Sponsor: Malek Bajbouj
Condition: PTSD

View study

RecruitingNCT06630065

the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to Ketamine

This study is recruiting. It focuses on depression and currently lists participation information in France.

In Paris

DepressionBehavioralOver 18 Years

Countries: France
Sponsor: Centre Hospitalier St Anne
Condition: Depression

View study

RecruitingNCT06671977

Safety study of Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Depression

This study is recruiting in the United States. It is testing Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT for Depression.

In West Haven

DepressionOtherFrom 21 Years to 65 Years

Countries: United States
Sponsor: Deepak C. D'Souza
Condition: Depression

View study

RecruitingNCT06105151

Safety study of Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Schizophrenia

This study is recruiting in China. It is testing Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules for Schizophrenia.

In Beijing

SchizophreniaOtherFrom 18 Years to 60 Years

Countries: China
Sponsor: Vigonvita Life Sciences
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.